AskVantage

Neuro42

Neuro42 is a startup headquartered in San Francisco, United States, founded in 2020. It has raised at least $22.2m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.

Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .

2020Founded
StartupStage
San Francisco, United StatesHeadquarters
HealthcareIndustry
$22.2m+Raised (SEC filings)
EarlyFunding stage
Healthcare
See it on the interactive mapBook a Briefing

Funding

Neuro42 has raised at least $22.2m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.

R&D ecosystem

Neuro42 sits inside the Silicon Valley and the Bay Area R&D ecosystem in the Global R&D Labs Directory.

Other startups in San Francisco

Related

Questions and answers

What does Neuro42 do?

Neuro42 is classed in healthcare in its filings with the US Securities and Exchange Commission.

How much has Neuro42 raised?

At least $22.2m, according to its Form D filings with the US Securities and Exchange Commission.

Where is Neuro42 based?

Neuro42 is headquartered in San Francisco, United States.

When was Neuro42 founded?

Neuro42 was founded in 2020.

Source record: SEC EDGAR (Form D filings).

© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.